Ischemic heart disease (coronary heart disease) remains a major threat to human health. Ischemia-reperfusion may activate some ion channels that cannot open under normal physiological conditions. One such channel is the ATP-sensitive potassium (K ATP ) channel, which opens in response to a drop in cellular ATP levels and a decrease in the ATP/ADP ratio during ischemia. Channel activation facilitates potassium ion efflux, encouraging hyperpolarization and action potential repolarization. The resulting shortening of the action potential duration decreases the total influx of sodium and calcium. This inhibition of calcium influx alleviates overloading of intracellular calcium, weakens myocardial contraction force and reduces myocardial oxygen consumption. Thus, the opening of K ATP channels plays an active role in protecting the heart against myocardial ischemia or hypoxia.
Astragaloside IV (AsIV) is a major active component of the native Chinese herb Astragalus membranaceus, which has been widely used for the treatment of cardiovascular disease in China. Recent studies have shown that AsIV may play a potential role in protecting the heart from myocardial ischemia. The mechanism of action may involve antioxidative and nitric oxide-inducing properties, reduction of [Ca 2+ ] i and sarcoplasmic reticulum (SR) Ca 2+ load, enhanced free radical removal, and decreased lipid peroxidation. 1, 2 AsIV may also improve cardiac function in rats after ischemia-reperfusion injury, 3 potentially due to prevention of [Ca 2+ ] i overload through improvements in energy metabolism, scavenging of oxygen free radicals, and inhibition of free radical production in the ischemic myocardium. The aim of this study was to investigate the effects of AsIV on K ATP channel currents and subunit
Preparation of the Ischemia-reperfusion Model in Ventricular Cardiomyocytes
The rats were anesthetized by intraperitoneal injection of sodium pentobarbital (100 mg/kg body weight). The heart was excised in oxygen-saturated Tyrode solution at 4 °C and was given retrograde perfusion in a non-recirculating Langendorff apparatus at constant pressure. All solutions were saturated with 95% O 2 /5% CO 2 and the perfusion system was kept at a temperature of 37 °C with a flow velocity of 8-10 mL/min. The isolated heart was first infused for 10 min with calcium-free Tyrode solution and then subjected to a 20 min global no-flow ischemia followed by a 45 min infusion of calcium-free Tyrode solution, and finally a 30 min infusion of low-calcium Tyrode solution containing 0.5 g/L of collagenase (Sigma-Aldrich Co. LLC, St Louis, MO, USA) and 20 mol/L Ca 2+ . The ventricle was cut into small pieces in KB solution and incubated for 10 min. The dispersed cells were harvested by filtering with a 200-μm nylon mesh. The isolated ventricular myocytes from the second and third incubations were washed with Medium 199 containing 10% calf serum by low speed centrifugation before they were used for experiments. When the calcium concentration of the filtrate returned to 1.25 mmol/L at room temperature, 70-80% rod-shaped calcium-resistant myocardial cells retaining normal physiologic and metabolic functions were acquired.
Whole-cell Patch-clamp Recordings
K ATP currents were recorded after 10-15 min of bath-application of the different drugs (glibenclamide 10 μmol/L, pinacidil 50 μmol/L and astragaloside IV (1 mg/L). Recordings were made with standard whole-cell patch clamp techniques. Membrane currents were recorded and analyzed with an Axoclamp 200B amplifier in conjunction with the pClamp 6.0 software and the analog/digital interface (Axon Instruments, Union City, CA, USA). Voltage commands were delivered using Clampex 8.2 running on an IBM-compatible computer.
Real-time Quantitative PCR Assays
Total RNA was extracted from isolated ventricular cardiomyocytes treated with different drugs using a TRIzol kit, and subjected to one-step real-time quantitative PCR. The reverse transcription reaction was performed using 50 ng of total RNA that was reverse transcribed into cDNA using oligo (dT) primer, then amplified for 40 cycles using two oligonucleotide (ODN) primers (Kir 6.1: 5'-GAGTGA-ACTGTCGCACCAGA-3' and 5'-CGATCACCAGAA-CTCAGCAA-3'; Kir6.2: 5'-CGATCACCAGAACTCA-GCAA-3' and 5'-GATGGGGACAAAACGCTG-3'; SUR2A: 5'-GGAGCAATCCAGACCAAGAT-3' and 5'-AGCCAGCAGAATGATGACAG-3'; SUR2B: 5'-ACCTGCTCCAGCACAAGAAT-3' and 5'-TCTCTT-CATCACAATGACCAGG-3'). Each PCR cycle was carried out for 30 s at 95 °C, 5 s at 95 °C and 30 s at 60 °C. Serial dilutions of cDNA were used to construct the standard curve. Each data point was repeated three times. Quantitative values were obtained from the threshold PCR cycle number (Ct) at which the increase of signal was associated with an exponential growth of PCR product after it started to be detected. The relative expression levels of the target gene were calculated according to the equation CT = (CT Target -CT Actin ) Timex -(CT Target -CT Actin ) Time 0.
Western Blotting Analysis
Cells were rinsed twice with ice-cold PBS following treatment and scraped into ice-cold buffer containing 10 mmol/L Tris-HCl (pH 7.5), 50 mmol/L NaCl, 50 mmol/L NaF, 10 mmol/L ethylenediaminetetraacetic acid (EDTA), 1 mmol/L DTT, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate, 1 mmol/L phenylmethylsulfonyl fluoride, 5 mmol/L leupeptin, and 5 mg/mL aprotinin. After lysis on ice for 30 min, the extracts were centrifuged for 15 min at 14000 g at 4 °C. The protein concentration of the supernatant was measured, and 20 g protein samples of cell lysate were mixed (1:1) with Laemmli sample buffer and incubated at 95 °C for 5 min. Proteins were subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis in 7.5% acrylamide gels. The separated proteins on the gels were transferred to polyvinylidene difluoride membranes, followed by Western blotting using specific antibodies. Membranes were blocked in 10 mmol/L Tris (pH 7.5), 100 mmol/L NaCl, and 0.1% Tween 20 containing 5% non-fat dry milk, followed by incubation with primary antibody. Membranes were washed 3 times and incubated with the appropriate horseradish peroxidase conjugated secondary antibody for 2 h. The immunocomplexes were visualized by chemiluminescence with the Phototope western blot detection system. The images were digitalized using the Gel Imaging System (Alpha Innotech Corp, USA). Band densitometry was carried out using NIH Image software. The expression levels of Kir6.1, Kir6.2, SUR2A, and SUR2B were expressed by ratios of these proteins to -actin (internal standard).
Statistical analysis
All the data were expressed as mean±SD. Statistical analysis was carried out using Student's t test and one-way ANOVA by SPSS12.0 software (SPSS Inc.). A value of P<0.05 was considered to be statistically significant.
RESULTS

Effect of Astragaloside IV on IK ATP in Rat Ventricular Cardiomyocytes
Under physiological conditions, K ATP channels in ventricular cardiomyocytes are predominantly closed. Therefore, the membrane was clamped at -40 mV and subjected to a ramp from -100 to 80 mV to induce background currents. An outward current in the control group was 83.51±23.67 pA, whereas it was significantly increased in IP group (211.45±33.67 pA; P<0.01 vs the control group). The outward current after ischemia-reperfusion was significantly blocked by glibenclamide (an antagonist of K ATP channels), so this current was identified as I KATP. In the presence of pinacidil (an agonist of K ATP channels), the outward current increased to 317.87±33.75 pA (P<0.01 vs IP group). Consistent with a K ATP channel-mediated mechanism of AsIV, the IP + AsIV group showed a significantly increased outward current amplitude (406.22±23.28 pA; P<0.01 vs IP group) ( Table 1 ). Figure 1 shows the outward current and voltage relationship. The current-voltage curve displayed an N shape, these voltage-dependent of currents were rising compared with the background currents, corresponding to the increased IK ATP. 
Effect of Astragaloside IV on the Expression of K ATP Channel Subunit mRNA
Quantitative real-time PCR demonstrated that the relative mRNA expression of the K ATP channel subunits SUR2A, Kir6.1, Kir6.2, SUR2B were significantly higher in the IP group than in the control group (P<0.01). Compared with the IP group, the subunit mRNA expression was significantly decreased in the IP + Gli group, and increased in the IP + AsIV and IP + Pin groups ( Table 2) . 
Effect of Astragaloside IV on K ATP Channel Subunit Protein expression
Western blotting showed that the SUR2A, Kir6.1 and Kir6.2 proteins were expressed in ventricular cardiomyocytes of the control group, while SUR2B was not detected. The expression of SUR2A, Kir6.1 and Kir6.2 proteins was increased in the IP group compared to the control group (P<0.05). In the IP + Gli group, the channel expression was inhibited, whereas both pinacidil and AsIV increased expression. AsIV caused a greater increase in K ATP channel subunit expression than did pinacidil (P<0.05, Table 3 , Figure 2 ). 
DISCUSSION
A decrease in cellular ATP during cardiac ischemia activates K ATP channels that are silent under normal physiological conditions. As a result of the increased potassium current, the plateau phase of the action potential is shortened, which decreases total calcium influx. This in turn reduces calcium-related contraction and thereby energy consumption, thus providing a protective effect through negative feedback. During reperfusion, intracellular overloading of calcium triggers calcium-dependent phospholipid signaling, which leads to arachidonic acid (AA) metabolism. This causes production of oxygen free radicals, and the ischemic myocardium fails to take full advantage of oxygen, worsening the ischemic injury.
K ATP channels were initially discovered by Noma in 1983, who used patch-clamping of cardiomyocytes of guinea pigs. 4, 5 The channels were classified as sarcolemmal K ATP channels and mitochondrial K ATP channels, and these are thought to play important roles in myocardial ischemia/hypoxia, ischemic-reperfusion injury, and ischemic preconditioning. [6] [7] [8] K ATP channels can increase myocardial oxygen supply while decreasing oxygen consumption, thus improving cardiac function and myocardial energy metabolism, preserving the normal structure of the cells, regulating vascular tension, and changing ion distributions inside and outside the cardiac myocytes. These actions are shared by many endogenous vascular-active substances, such as adenosine, vasoactive intestinal peptide, and calcitonin gene related peptide, which are related to various signal molecules and signal transduction processes. [9] [10] [11] Myocardial protection research has increasingly focused on K ATP channels as a mediator of endogenous and exogenous vascular dilation and contraction. 12, 13 Representative potassium channel openers, including cromakalin, diazoxide and pinacidil, may facilitate potassium ion efflux to induce membrane hyperpolarization and repolarization, counteracting the opening of voltage-dependent calcium channels. The effects are mediated by inhibition of the formation of inositol triphosphate, reductions in vascular contraction factors that induce cytoplasmic release of Ca 2+ , weakening of the sensitivity of organelles to Ca 2+ , and acceleration of the clearing of intracellular Ca 2+ by Na + -Ca 2+ exchangers to decrease intracellular free calcium. [14] [15] [16] [17] When K ATP channels are open, cardiac myocytes can be protected by facilitation of ATP synthesis or inhibition of calcium overloading. Further, protection can be achieved by the promotion of oxygen free radical production during ischemia and inhibition of oxygen free radical production during reperfusion. K ATP antagonists, including glibenclamide and cibenzoline, can block protective effect of K ATP currents in the dog myocardium. In general, if an ion current was blocked by at least 100 μmol/L glibenclamide, we considered this to be mediated by the K ATP channel. 18 In this study, the ischemia-reperfusion injury was induced by 30 min of ischemia, followed by 45 min of reperfusion. Under these ischemic and hypoxic conditions, I KATP was significantly increased, and glibenclamide 10 μmol/L could block most of the K ATP current. In contrast, pinacidil could significantly increase IK ATP .
Some studies have indicated that AsIV can improve post-ischemic cardiac function, prevent overloading of calcium by stimulating calcium extrusion through calcium pumps, and increase the levels of superoxide dismutase to reduce accumulation of free radicals during myocardial ischemia, thus preventing lipid peroxidation injury. 19, 20 The present study indicates that AsIV could also open K ATP channels, with similar efficacy to pinacidil.
The K ATP channel is a tetramer containing the inward rectifier potassium channel protein Kir and the ATP-binding protein at a ratio of 1:1. The Kir protein forms an ion channel at the center of the tetramer, while the ATP-binding protein resides at the outskirts and determines the function of K ATP . The main types of myocardial K ATP channel subunits are SUR2A and Kir6.2, and vascular smooth muscle channels include SUR2B and Kir6.1. [21] [22] [23] [24] [25] In this study, the expression of SUR2A, Kir6.1 and Kir6.2 were observed in the cardiomyocytes, but there was almost no expression of SUR2B. This result is consistent with previous reports. 26, 27 In the IP group, which showed increased K ATP currents, the expression of the K ATP channel subunits was significantly increased, providing further support for a role of these channels in the ischemic myocardium. Pinacidil increased the expression of channel subunits to protect cardiomyocytes after ischemia-reperfusion injury, while glibenclamide could block this effect. Meanwhile, AsIV also significantly increased the expression of the K ATP channel subunits, and the increase appeared to be larger than the change observed after pinacidil. We suggest that AsIV may facilitate the opening of K ATP channels.
In conclusion, AsIV is an opener of the K ATP channel, and may thereby facilitate potassium ion efflux and induce membrane hyperpolarization and accelerate action potential repolarization, with resulting protective effects. The up-regulation of several protein subunits will also facilitate the opening of K ATP channels, suggesting that AsIV is likely to have a cardioprotective effect after ischemia-reperfusion injury.
